MARC details
000 -LEADER |
fixed length control field |
11152cam a2200553 i 4500 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
OCoLC |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20221101231536.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
151124s2017 moua b 001 0 eng d |
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
LC control number |
2015046359 |
011 ## - LINKING LIBRARY OF CONGRESS CONTROL NUMBER [OBSOLETE] |
Local cataloguing issues note |
MARC Score : 11050(25500) : OK |
011 ## - LINKING LIBRARY OF CONGRESS CONTROL NUMBER [OBSOLETE] |
Local cataloguing issues note |
Direct Search Result |
011 ## - LINKING LIBRARY OF CONGRESS CONTROL NUMBER [OBSOLETE] |
Local cataloguing issues note |
BIB MATCHES WORLDCAT |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
0323311121 |
Qualifying information |
pbk. |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9780323311120 |
Qualifying information |
pbk. |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(OCoLC)930496906 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
NLM |
Language of cataloging |
eng |
Description conventions |
rda |
Transcribing agency |
NLM |
Modifying agency |
DLC |
-- |
YDXCP |
-- |
VET |
-- |
IBI |
-- |
CDX |
-- |
OCLCF |
-- |
OCLCO |
-- |
OCLCQ |
-- |
ATU |
042 ## - AUTHENTICATION CODE |
Authentication code |
pcc |
050 00 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RM300 |
Item number |
.C59 2017 |
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
615.1 |
Edition number |
23 |
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) |
Classification number |
615.1 CLA |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Clayton, Bruce D., |
Dates associated with a name |
1947- |
Relator term |
author. |
9 (RLIN) |
418127 |
245 10 - TITLE STATEMENT |
Title |
Basic pharmacology for nurses / |
Statement of responsibility, etc. |
Bruce D. Clayton, Michelle Willihnganz. |
250 ## - EDITION STATEMENT |
Edition statement |
17 edition. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
St. Louis, Missouri : |
Name of producer, publisher, distributor, manufacturer |
Elsevier, |
Date of production, publication, distribution, manufacture, or copyright notice |
[2017] |
264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Date of production, publication, distribution, manufacture, or copyright notice |
©2017 |
300 ## - PHYSICAL DESCRIPTION |
Extent |
xiv, 832 pages : |
Other physical details |
illustrations ; |
Dimensions |
28 cm |
336 ## - CONTENT TYPE |
Content type term |
text |
Content type code |
txt |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
unmediated |
Media type code |
n |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
volume |
Carrier type code |
nc |
Source |
rdacarrier |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc. note |
Includes bibliographical references and index. |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Machine generated contents note: UNIT I FOUNDATIONS OF PHARMACOLOGY -- 1.Drug Definitions, Standards, and Information Sources -- Drug Names, Standards, Legislation, And Development In The United States -- Drug Names -- Sources of Drug Standards and Drug Information -- United States Drug Legislation -- New Drug Development -- Drug Names, Standards, And Legislation In Canada -- Canadian Drug Names -- Sources of Canadian Drug Standards -- Canadian Drug Legislation -- 2.Basic Principles of Drug Action and Drug Interactions -- Basic Principles Related to Drug Therapy -- Drug Actions -- Drug Interactions -- 3.Drug Action Across the Life Span -- Factors That Affect Drug Therapy -- Factors That Influence Drug Actions -- Therapeutic Drug Monitoring -- Nursing Implications When Monitoring Drug Therapy -- Genetics and Drug Metabolism -- 4.The Nursing Process and Pharmacology -- The Nursing Process -- Relating the Nursing Process to Pharmacology -- 5.Patient Education to Promote Health -- |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Note continued: Three Domains of Learning -- Principles of Teaching and Learning -- Strategies for Health Teaching -- UNIT II ILLUSTRATED ATLAS OF MEDICATION ADMINISTRATION -- 6.Principles of Medication Administration and Medication Safety -- Legal and Ethical Considerations -- Patient Charts -- Drug Distribution Systems -- Disposal of Unused Medicines -- Medication Orders -- Medication Safety -- Seven Rights of Drug Administration -- 7.Percutaneous Administration -- Administration Of Topical Medications To The Skin -- Administration of Creams, Lotions, and Ointments -- Patch Testing for Allergens -- Administration of Nitroglycerin Ointment -- Administration of Transdermal Drug Delivery Systems -- Administration of Topical Powders -- Administration Of Medications To Mucous Membranes -- Administration of Sublingual and Buccal Tablets -- Administration of Eyedrops and Ointment -- Administration of Eardrops -- Administration of Nose Drops -- Administration of Nasal Spray -- |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Note continued: Administration of Medications by Inhalation -- Administration of Medications by Oral Inhalation -- Administration of Vaginal Medications -- Administration of a Vaginal Douche -- 8.Enteral Administration -- Administration Of Oral Medications -- Administration of Solid-Form Oral Medications -- Administration of Liquid-Form Oral Medications -- Administration of Medications by Nasogastric Tube -- Administration of Enteral Feedings via Gastrostomy or Jejunostomy Tube -- Administration of Rectal Suppositories -- Administration of a Disposable Enema -- 9.Parenteral Administration: Safe Preparation of Parenteral Medications -- Safe Preparation, Administration, and Disposal of Parenteral Medications and Supplies -- Equipment Used for Parenteral Administration -- Safety Systems for Parenteral Preparation, Administration, and Disposal -- Parenteral Dose Forms -- Preparation of Parenteral Medication -- |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Note continued: 10.Parenteral Administration: Intradermal, Subcutaneous, and Intramuscular Routes -- Administration of Medication by the Intradermal Route -- Administration of Medication by the Subcutaneous Route -- Administration of Medication by the Intramuscular Route -- 11.Parenteral Administration: Intravenous Route -- Equipment Used for Intravenous Therapy -- Intravenous Dose Forms -- Administration of Medications by the Intravenous Route -- Basic Guidelines for the Intravenous Administration of Medications -- Monitoring Intravenous Therapy -- UNIT III DRUGS THAT AFFECT THE AUTONOMIC AND CENTRAL NERVOUS SYSTEMS -- 12.Drugs That Affect the Autonomic Nervous System -- The Central and Autonomic Nervous Systems -- The Autonomic Nervous System -- 13.Drugs Used for Sleep -- Sleep and Sleep Pattern Disturbance -- Sedative-Hypnotic Therapy -- Drug Therapy for Sleep Disturbance -- 14.Drugs Used for Parkinson's Disease -- Parkinson's Disease -- |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Note continued: Drug Therapy for Parkinson's Disease -- 15.Drugs Used for Anxiety Disorders -- Anxiety Disorders -- Drug Therapy for Anxiety Disorders -- 16.Drugs Used for Depressive and Bipolar Disorders -- Depressive And Bipolar Disorders -- Depressive Disorder -- Treatment of Depressive and Bipolar Disorders -- Drug Therapy for Depressive and Bipolar Disorders -- Drug Therapy for Depressive Disorders -- 17.Drugs Used for Psychoses -- Psychosis -- Treatment of Psychosis -- Drug Therapy for Psychosis -- Adverse Effects of Antipsychotic Drug Therapy -- Other Adverse Effects -- 18.Drugs Used for Seizure Disorders -- Seizure Disorders -- Descriptions of Seizures -- Anticonvulsant Therapy -- Drug Therapy for Seizure Disorders -- 19.Drugs Used for Pain Management -- Pain -- Pain Management -- UNIT IV Drugs That Affect The Cardiovascular System -- 20.Introduction to Cardiovascular Disease and Metabolic Syndrome -- Cardiovascular Diseases -- Metabolic Syndrome -- |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Note continued: 21.Drugs Used to Treat Dyslipidemias -- Atherosclerotic Cardiovascular Disease -- Treatment of Hyperlipidemias -- Drug Therapy for Hyperlipidemias -- 22.Drugs Used to Treat Hypertension -- Hypertension -- Treatment of Hypertension -- Drug Therapy for Hypertension -- 23.Drugs Used to Treat Dysrhythmias -- Dysrhythmias -- Treatment for Dysrhythmias -- Drug Therapy for Dysrhythmias -- 24.Drugs Used to Treat Angina Pectoris -- Angina Pectoris -- Treatment of Angina Pectoris -- Drug Therapy for Angina Pectoris -- 25.Drugs Used to Treat Peripheral Vascular Disease -- Peripheral Vascular Disease -- Treatment of Peripheral Vascular Disease -- Drug Therapy for Peripheral Vascular Disease -- 26.Drugs Used to Treat Thromboembolic Disorders -- Thromboembolic Diseases -- Treatment of Thromboembolic Diseases -- Drug Therapy for Thromboembolic Diseases -- 27.Drugs Used to Treat Heart Failure -- Heart Failure -- Treatment of Heart Failure -- |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Note continued: Drug Therapy for Heart Failure -- 28.Drugs Used for Diuresis -- Drug Therapy With Diuretics -- UNIT V DRUGS THAT AFFECT THE RESPIRATORY SYSTEM -- 29.Drugs Used to Treat Upper Respiratory Disease -- Upper Respiratory Tract Anatomy and Physiology -- Common Upper Respiratory Diseases -- Treatment of Upper Respiratory Diseases -- Drug Therapy for Upper Respiratory Diseases -- 30.Drugs Used to Treat Lower Respiratory Disease -- Lower Respiratory Tract Anatomy and Physiology -- Common Lower Respiratory Diseases -- Treatment of Lower Respiratory Diseases -- Drug Therapy for Lower Respiratory Diseases -- UNIT VI DRUGS THAT AFFECT THE DIGESTIVE SYSTEM -- 31.Drugs Used to Treat Oral Disorders -- Oral Anatomy -- Mouth Disorders -- Drug Therapy for Mouth Disorders -- 32.Drugs Used to Treat Gastroesophageal Reflux and Peptic Ulcer Disease -- Physiology Of The Stomach -- Common Stomach Disorders -- Goals of Treatment -- Drug Therapy -- |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Note continued: 33.Drugs Used to Treat Nausea and Vomiting -- Nausea And Vomiting -- Common Causes of Nausea and Vomiting -- Drug Therapy for Selected Causes of Nausea and Vomiting -- 34.Drugs Used to Treat Constipation and Diarrhea -- Constipation -- Diarrhea -- Treatment of Altered Elimination -- UNIT VII DRUGS THAT AFFECT THE ENDOCRINE SYSTEM -- 35.Drugs Used to Treat Diabetes Mellitus -- Diabetes Mellitus -- Complications of Diabetes Mellitus -- Treatment of Diabetes Mellitus -- Drug Therapy for Diabetes Mellitus -- Incretin-Based Antidiabetic Therapy -- 36.Drugs Used to Treat Thyroid Disease -- Thyroid Gland -- Thyroid Diseases -- Treatment of Thyroid Diseases -- Drug Therapy for Thyroid Diseases -- 37.Corticosteroids -- Corticosteroids -- 38.Gonadal Hormones -- The Gonads And Gonadal Hormones -- Drug Therapy With Gonadal Hormones -- UNIT VIII DRUGS THAT AFFECT THE REPRODUCTIVE SYSTEM -- 39.Drugs Used in Obstetrics -- Obstetrics -- Drug Therapy in Pregnancy -- |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Note continued: 40.Drugs Used in Men's and Women's Health -- Vaginitis -- Drug Therapy for Leukorrhea and Genital Infections -- Drug Therapy for Contraception -- Drug Therapy for Benign Prostatic Hyperplasia -- Drug Therapy for Erectile Dysfunction -- UNIT IX DRUGS THAT AFFECT OTHER BODY SYSTEMS -- 41.Drugs Used to Treat Disorders of the Urinary System -- Urinary Tract Infections -- Drug Therapy for Urinary Tract Infections -- Drug Therapy for Overactive Bladder Syndrome -- 42.Drugs Used to Treat Glaucoma and Other Eye Disorders -- Anatomy And Physiology Of The Eye -- General Considerations for Topical Ophthalmic Drug Therapy -- Glaucoma -- Drug Therapy for Glaucoma -- Other Ophthalmic Agents -- 43.Drugs Used to Treat Cancer -- Cancer And The Use Of Antineoplastic Agents -- Drug Therapy for Cancer -- 44.Drugs Used to Treat the Musculoskeletal System -- Muscle Relaxants And Neuromuscular Blocking Agents -- Drug Therapy for Muscle Disorders -- 45.Antimicrobial Agents -- |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Note continued: Antimicrobial Agents -- Drug Therapy for Infectious Disease -- UNIT X DRUGS THAT AFFECT THE GENERAL HEALTH OF THE BODY -- 46.Nutrition -- Principles Of Nutrition -- Malnutrition -- Therapy for Malnutrition -- 47.Herbal and Dietary Supplement Therapy -- Herbal Medicines, Dietary Supplements, and Rational Therapy -- 48.Substance Abuse -- Classification of Substance Abuse -- Substance Use Disorders -- Signs of Impairment -- Screening for Alcohol and Substance Abuse -- Health Professionals and Substance Abuse -- Principles of Treatment for Substance Abuse -- 49.Miscellaneous Agents -- APPENDIXES -- A.Nomogram for Calculating the Body Surface Area of Adults, Children, and Infants -- B.Template for Developing a Written Record for Patients to Monitor Their Own Therapy. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Pharmacology. |
9 (RLIN) |
345436 |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Nursing. |
9 (RLIN) |
321532 |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Willihnganz, Michelle J., |
Relator term |
author. |
9 (RLIN) |
913822 |
776 18 - ADDITIONAL PHYSICAL FORM ENTRY |
Record control number |
(OCoLC)918594736 |
-- |
(OCoLC)948631652 |
907 ## - LOCAL DATA ELEMENT G, LDG (RLIN) |
a |
.b15669403 |
b |
22-08-17 |
c |
28-06-16 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Koha item type |
Book |
945 ## - LOCAL PROCESSING INFORMATION (OCLC) |
a |
615.1 CLA |
g |
1 |
i |
A553575B |
j |
0 |
l |
nmain |
o |
- |
p |
$114.95 |
q |
- |
r |
- |
s |
- |
t |
0 |
u |
3 |
v |
1 |
w |
0 |
x |
3 |
y |
.i13508787 |
z |
09-08-16 |
998 ## - LOCAL CONTROL INFORMATION (RLIN) |
-- |
b |
-- |
n |
Operator's initials, OID (RLIN) |
12-07-16 |
Cataloger's initials, CIN (RLIN) |
m |
First date, FD (RLIN) |
a |
-- |
eng |
-- |
mou |
-- |
0 |